Ryan Langston
Stock Analyst at TD Cowen
(1.43)
# 3,250
Out of 4,714 analysts
12
Total ratings
40%
Success rate
-7.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UHS Universal Health Services | Maintains: Buy | $275 → $251 | $178.89 | +40.31% | 3 | Nov 26, 2024 | |
| ELV Elevance Health | Maintains: Buy | $589 → $484 | $371.56 | +30.26% | 2 | Oct 21, 2024 | |
| ASTH Astrana Health | Initiates: Buy | $66 | $32.18 | +105.10% | 1 | Oct 14, 2024 | |
| ADUS Addus HomeCare | Maintains: Buy | $128 → $137 | $124.59 | +9.96% | 4 | Aug 8, 2024 | |
| EHAB Enhabit | Maintains: Market Perform | $12 → $11 | $7.87 | +39.77% | 2 | Mar 11, 2024 |
Universal Health Services
Nov 26, 2024
Maintains: Buy
Price Target: $275 → $251
Current: $178.89
Upside: +40.31%
Elevance Health
Oct 21, 2024
Maintains: Buy
Price Target: $589 → $484
Current: $371.56
Upside: +30.26%
Astrana Health
Oct 14, 2024
Initiates: Buy
Price Target: $66
Current: $32.18
Upside: +105.10%
Addus HomeCare
Aug 8, 2024
Maintains: Buy
Price Target: $128 → $137
Current: $124.59
Upside: +9.96%
Enhabit
Mar 11, 2024
Maintains: Market Perform
Price Target: $12 → $11
Current: $7.87
Upside: +39.77%